Cellomics signs lease at Bridgeside Point in Pittsburgh

PITTSBURGH – Locally-based Cellomics Inc. has signed a long-term lease on the new Bridgeside Point building at the Pittsburgh Technology Center. Slated for completion in December 2001, the 153,000 sq. ft., five-story building will be a state-of-the-art biotechnology facility.

The new facility will allow Cellomics to consolidate its Harmar Township, Pa., operations with its manufacturing facility. The company will sublease a portion of space in the building, which is being developed by Ferchill Group. Colliers Penn served as broker to Cellomics.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish